Article Details
Retrieved on: 2018-02-27 14:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Earlier this year, Axio Biosolutions had raised $7.4mn in a Series B funding round led by Ratan Tata's UC- RNT, along with existing investors <b>Accel Partners</b> and IDG Ventures India. As the first Indian company to launch an indigenously developed emergency haemostat for trauma care, Axio Biosolutions ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here